Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: FutTheWuk / Re: Revenue recognition...right here
11
Jan 24, 2013 02:46PM
2
Jan 24, 2013 05:12PM

opc
Jan 24, 2013 05:21PM

"Could be a licensee has a pending public offering that will provide additional revenues from which they plan to pay the license fee. PDS might agree to a contingency based on that situation being completed for some of the fee."

You might argue that you should have used "funds" instead of revenues. However, a license would never be written with the contingency being the licensee complete a public offering, that just wouldn't make sense. So it would seem that you are stating that the "revenues" would be a factor in calculating the licensing fee.

Share
New Message
Please login to post a reply